February 11, 2016
Authored and Edited by Justin N Mullen; Amanda K. Murphy, Ph.D.
On February 2, the U.S. Patent and Trademark Office (USPTO) hosted one of a series of Boardside Chats by the Patent Trial and Appeal Board (PTAB) to discuss, among other topics, ex parte appeal pendency. While the current PTAB statistics dashboard (reproduced below) indicates that the majority of current ex parte appeals remain pending for more than 14 months, the Board has reduced its ex parte appeal inventory by over 4% in the past three months.

Specifically, the Board has reduced its backlog of pending ex parte appeals by 1,665 appeals from September 8, 2015 to January 19, 2016, as shown in the bar graph below. While the total reduction may appear to merely be an incremental improvement, the rate of reduction shows significant improvement over fiscal year 2014, during which the number of pending ex parte appeals actually increased by 69 appeals.

The Boardside Chat also provided pendency statistics for appeals from each Technology Center (TC). As shown in the chart below, appeal pendency varies among Technology Centers. For example, ex parte appeals in applications handled by TC 2400, which handles inventions directed to cable television, computer networks, multiplex communications, voice‑over‑IP, compression, cryptography, and security, currently face the longest wait for a Board decision. In contrast, appeals from T Cs 1600 and 1700, which focus on inventions in the biotechnology and chemistry fields, are processed by the Board about 30% faster, with 27.7 and 24.5 months to a Board Decision on average, respectively.

As ex parte appeal pendency changes over time and varies among technology areas, Applicants may wish to consult the current appeal pendency statistics for the Technology Center assigned to their application when contemplating whether to reopen prosecution before the Examiner or appeal to the Board. Such statistics may assist Applicants in making patent portfolio decisions based on current business needs.
As with other Boardside Chats, the USPTO has provided the presentation materials to the public, selections from which were incorporated into this post.
Aqua Products v. Matal, Boardside Chat, ex parte reexamination, patentability, United States Patent and Trademark Office (USPTO)
Copyright © 2016 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP.
DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.
Articles
California Reaches Record $12.75 Million CCPA Settlement with General Motors Over Driver Data
June 4, 2026
At the PTAB Blog
IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026
May 26, 2026
Conference
19th Annual Forum on Pharma & Biotech Patent Litigation in Europe
May 19-20, 2026
Amsterdam
Webinar
Changes at the PTAB from Settled Expectations to Real Parties in Interest to Director Involvement
May 18, 2026
Webinar
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.